Sunaciclib

N/A

Report date: 2025/06/13 14:51:41
NME

Base Information

Drug NameSunaciclib
Drug Alias NameAU-07
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAucentra Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAucentra Therapeutics Pty Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursHematologic NeoplasmsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A